Medical News

RSS

Democrats seek to investigate funding for faith-based HIV/AIDS, abstinence initiatives

Some Democrats on the House International Relations Committee said they want to investigate funding for faith-based HIV/AIDS and abstinence-until-marriage initiatives receiving money under the President's Emergency Plan for AIDS Relief to determine whether taxpayer money is being used appropriately, the Boston Globe reports.

5 Dec 2006

Program in Iran provides treatment for HIV-positive people

An HIV/AIDS treatment and prevention program in Iran founded by two local physicians is providing antiretroviral drugs and clean needles to HIV-positive people in the country, the Washington Post reports.

5 Dec 2006

Chinese province to require couples to receive HIV tests before marriage

China's Yunnan Province beginning Jan. 1, 2007, will require couples to receive HIV tests before getting married, Xinhua/People's Daily reports.

5 Dec 2006

Low-income Medicare beneficiaries will have trouble getting medications in January 2007

Some pharmacists and advocates have raised concerns that many low-income Medicare beneficiaries "will again have trouble getting medications next month, as they did in January of this year," when the Medicare prescription drug benefit began, the New York Times reports.

5 Dec 2006

FDA advisory panel on drug-eluting stents to include physicians with industry ties

FDA will waive rules that prohibit advisory panel members from having financial ties to companies whose products are being reviewed to allow six physicians with ties to Johnson & Johnson and other heart device manufacturers to serve on a panel examining the possible health risks of drug-eluting stents, Bloomberg/South Florida Sun-Sentinel reports.

5 Dec 2006

Just how safe is that chicken?

A report by a consumer group in the U.S. has found that most of the chicken sold in grocery stores could contain bacteria that cause foodborne illnesses.

5 Dec 2006

Susan Winckler appointed as acting FDA Chief of Staff

Dr. Andrew von Eschenbach, Acting Commissioner of Food and Drugs (FDA), today announced the appointment of Susan C. Winckler, RPh, Esq., as the agency's Acting Chief of Staff. Ms. Winckler is replacing Patrick Ronan who announced his resignation last week after several years of service at the FDA.

5 Dec 2006

Another food scare in the U.S.

In the latest food scare to hit the U.S. an outbreak of E. coli has made two people seriously ill and sickened at least 22 others in New Jersey.

5 Dec 2006

Vascular targeted nanoparticles for imaging and treatment of brain tumors

Combining two promising approaches to diagnosing and treating cancer, a multidisciplinary research team at the University of Michigan has created a targeted multifunctional polymer nanoparticle that successfully images and kills brain tumors in laboratory animals.

4 Dec 2006

Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid

Waiting a day or more to get lab results back from the doctor's office soon could become a thing of a past.

4 Dec 2006

High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals

In attempt to identify biological markers, or biomarkers, that can signal the presence of cancer and help oncologists determine the best course of therapy when cancer is present, teams of investigators are scouring stored tissue samples obtained from thousands of cancer patients.

4 Dec 2006

Nonlithographic fabrication of microfluidic devices

Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications.

4 Dec 2006

An effective malaria vaccine by 2025

A report by the world's leading international health organizations today calls for joint action to accelerate the development and licensing of a highly effective malaria vaccine.

4 Dec 2006

Pfizer stops all Torcetrapib trials

On December 2, 2006, FDA was notified that Pfizer will suspend a large, Phase 3 trial evaluating the investigational cardiovascular therapy torceptrapib/atorvastatin (T/A) due to an increased rate of mortality (death) in patients receiving the combination compared to those receiving atorvastatin alone.

4 Dec 2006